Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Alzheimer disease

MRI and CSF biomarkers in AD—accuracy and temporal change

Nature Reviews Neurology volume 6, pages 650–651 (2010)Cite this article

Subjects

Alzheimer disease (AD) biomarkers reflect specific features of AD pathology. These biomarkers may be used in the diagnosis and staging of AD, or may act as surrogate end points in clinical trials. Thus, a thorough understanding of the diagnostic accuracy of and longitudinal change in cerebrospinal fluid and MRI AD biomarkers is important.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. De Meyer, G. et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol. 67, 949–956 (2010).

    Article  Google Scholar 

  2. Vemuri, P. et al. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 75, 143–151 (2010).

    Article  CAS  Google Scholar 

  3. Jack, C. R. Jr et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119–128 (2010).

    Article  CAS  Google Scholar 

  4. Perrin, R. J., Fagan, A. M. & Holtzman, D. M. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916–922 (2009).

    Article  CAS  Google Scholar 

  5. Kester, M. I. et al. Diagnostic impact of CSF biomarkers in a local hospital memory clinic. Dement. Geriatr. Cogn. Disord. 29, 491–497 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

    Niels D. Prins

  2. Department of Neurology, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands

    John C. van Swieten

Authors
  1. Niels D. Prins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John C. van Swieten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niels D. Prins.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prins, N., van Swieten, J. MRI and CSF biomarkers in AD—accuracy and temporal change. Nat Rev Neurol 6, 650–651 (2010). https://doi.org/10.1038/nrneurol.2010.173

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2010.173

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing